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Abstract
Background. Phagocytosis of IgG- or complement-
opsonized bacteria and antibody production by
lymphocytes are regulated by cell surface receptors
for IgG (FcgRI, FcgRII and FcgRIII) and comple-
ment (CR1 and CR3). We measured the effect of
uraemia and dialysis treatment on FcgR and CR
expression on leukocytes in blood.
Methods. Blood samples were obtained from chil-
dren: 40 treated with peritoneal dialysis (PD), 23 with
haemodialysis (HD), 46 not yet dialysed (CRF) and 33
healthy (HC). White blood cells, isolated from
EDTA–blood by centrifugation after cell fixation
with paraformaldehyde, were labelled with FITC-
conjugated CD16 (FcgRIII), CD32 (FcgRII), CD64
(FcgRI), CD11b (CR3) and CD35 (CR1) monoclonal
antibodies and analysed by flow cytometry.
Results. In PD, HD, CRF and HC, monocytes and
neutrophils were all positive for FcgR and CR, except
for CD16 on monocytes (20% positive). Lymphocytes
expressed CD16 and CD32 but not CD64. PD, HD
and CRF children had lower percentages of CD16þ
and CD32þ lymphocytes compared with HC. The
percentage of CD11bþ lymphocytes was lower only
in PD and the percentage of CD35þ lymphocytes
was lower in HD and CRF compared with HC. The
median CD32 mean fluorescense intensity (MFI) on
lymphocytes, monocytes and neutrophils was lower
in PD, HD and CRF compared with HC. On the
other hand, CD11b MFI on lymphocytes, monocytes
and neutrophils was higher in PD, HD and CRF
children compared with HC. CD16 and CD64 MFI
were not different among the groups and CD35 MFI
was only lower on lymphocytes from PD, HD and
CRF compared with HC.
Conclusions. In children with chronic renal failure,
whether dialysed or not, FcgRII expression on
lymphocytes, monocytes and neutrophils was reduced
and CR3 expression was increased. Furthermore, CR1
expression on lymphocytes, important for the humoral
response, was lower in children with renal failure. Age
and uraemia are associated with these abnormalities
and might contribute to impaired immune function
in children with chronic renal failure.
Keywords: chronic renal failure; complement
receptors; FcgR; haemodialysis; immunoglobulin
G receptors; peritoneal dialysis
Introduction
Immunoglobulin (Ig) and complement receptors are
important for the interaction between humoral and
cellular immunities. These receptors bind to IgG- and
complement-opsonized micro-organisms and facili-
tate phagocytosis. Immunoglobulin receptors for IgG,
also called FcgR, can be divided into three different
types, designated FcgRI (CD64), FcgRII (CD32) and
FcgRIII (CD16), each with unique binding character-
istics for IgG and its subclasses [1]. FcgR are present
on monocytes, neutrophils, natural killer cells and
lymphocytes.
Four different complement receptors (CR) are
known: CR1, CR2, CR3 and CR4. CR1 (CD35), an
opsonic receptor for C3b, is present on neutrophils
and monocytes that mediate phagocytosis. CR1 on B
lymphocytes, together with CR2, mediate lymphocyte
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activation. The cleavage of C3b by factors H and I
results in an inactive complement protein, iC3b, which
has a low affinity for CR1. However, iC3b still has
an important opsonic activity, binding also to CR3
(CD11b) and CR4. CR3 and CR4 augment the activ-
ities of Fc receptors and CR1 in activating phago-
cytosis [2,3]. CR1 and CR3 are especially important
for inducing the phagocytosis of complement-coated
bacteria.
Little information is available on the expression of
FcgR and CR in the blood of patients with chronic
renal failure, whether treated with dialysis or not. Some
studies have investigated their expression on peritoneal
macrophages [4,5]; others have measured their expres-
sion during a haemodialysis session in order to explore
the effects of the dialyser membrane and the dialysis
treatment itself on receptor expression. Some authors
have described an increased CD16 (FcgRIII)-positive
monocyte population in peritoneal dialysis and haemo-
dialysis patients compared with healthy controls, a
phenotype that has been linked to tissue macro-
phages in the context of the stage of maturation [6–9].
During haemodialysis, this CD16þ monocyte popula-
tion decreased [8,9]. No difference was found between
adult peritoneal dialysis patients and healthy controls
by Brauner et al. [7] in the expression of CD11b (CR3)
on monocytes. No information is available on the
expression of FcgRII (CD32) and FcgRI (CD64) on
leukocytes in the blood of stable peritoneal dialysis
and haemodialysis patients. In children on peritoneal
dialysis, a longitudinal study (3 years) has been
performed by Wasik et al. [10] on CD16 (FcgRIII)
and CD35 (CR1) expression on phagocytic cells. They
found a temporary increase of the percentages of
CD16þ and CD35þ neutrophils in blood, during the
first 3 months of peritoneal dialysis. Studies on the
effect of age on receptor expression in children are
not available.
In order to further explore the mechanisms respon-
sible for immune system abnormalities during chronic
renal failure in childhood and the influence of dialysis
on them, the FcgR and CR expression of white blood
cells (WBC) were analysed in children with chronic
renal failure not yet dialysed and in children treated
with haemodialysis or peritoneal dialysis.
Subjects and methods
Blood samples were obtained for FcgR and CR expression
analysis from children: 40 treated with peritoneal dialysis
(PD), 23 on haemodialysis (HD), 46 with chronic renal failure
not yet dialysed (CRF) and 33 healthy controls (HC). Blood
samples were drawn just before starting the haemodialysis
session in the HD children. The medians (ranges) of age,
glomerular filtration rate (GFR) and duration of dialysis
treatment are summarized in Table 1. In CRF patients, the
GFR was estimated by the Schwartz formula [11]. Of those,
30% (14/46) had moderate renal insufficiency (30–60ml/
min/1.73m2), 20% (9/46) a severe renal insufficiency
(15–30ml/min/1.73m2) and 50% (23/46) pre-terminal renal
failure (15ml/min/1.73m2). The primary renal diseases
of the patients are listed in Table 2. Blood samples were
collected in EDTA tubes by venipuncture. WBC were iso-
lated by centrifugation (500 g, 10min, 4C) after cell fixation
with paraformaldehyde 1% (PFA). Erythrocytes were lysed
with ammonium chloride (0.155mol/l) and potassium-EDTA
(0.5mmol/l) and WBC were subsequently washed with PBAP
[phosphate-buffered saline solution supplemented with 0.5%
(wt/vol) bovine serum albumin, 0.01% (wt/vol) sodium azide
and 0.5mmol/l potassium-EDTA). WBC were again fixed
with 4% PFA for 10min followed by centrifugation (500 g,
10min, 4C). The Fc receptor of WBC was blocked with 10%
normal human pool serum. WBC were incubated for 30min
on ice in the dark with saturating amounts of FITC-labelled
CD16 (FcgRIII) obtained from the CLB Sanquin Blood
Supply Foundation, Amsterdam, the Netherlands (clone
CLB-Fc-gran/1, 5D2), CD32 (FcgRII) (clone AT10;
Instruchemie Hilversum B.V., The Netherlands), CD64
(FcgRI) (clone P3/NS1/1-Ag4-1; Medarex, Annandale,
USA), CD11b (CR3) (clone CLB-mon-gran/1, B2; CLB)
and CD35 (CR1) (clone E11; Instruchemie) monoclonal
antibodies (mAb). After incubation, the cells were washed
with PBAP and again fixed with PFA 1%. Flow cytometry
was performed within the following 12 h with the FACScan
(Beckton Dickinson Immunocytometry Systems, San Jose,
CA, USA). Lymphocytes, monocytes and neutrophils were
distinguished on the basis of their size and granularity by
Table 2. Primary renal diseases of the patients
PD HD CRF
Urological malformation 13 7 17
Glomerulopathy 10 3 10
Haemolytic uraemic syndrome 4 3 4
Metabolic disease 1 2 1
Congenital disease 7 4 12
Other diseases 3 1 2
Unknown 2 3 0
Total 40 23 46
Urological malformation: 22 children with urethral values, 12 reflux
nephropathy, one bilateral duplicated kidney, one neurogenic
bladder, one bladder exstrophy. Glomerulopathy: 12 children with
focal segmental glomerulosclerosis, five congenital nephrotic syn-
drome, two rapidly progressive glomerulonephritis, one Alport’s
syndrome, two Henoch–Scho¨nlein purpura nephritis, one lupus
nephritis. Congenital disease: nine children with renal dysplasia, six
polycystic kidney disease, seven nephronophtisis, one tuberous
sclerosis. Other diseases: five children with acute tubular necrosis,
one bilateral Wilms’ tumour.
Table 1. Patients’ characteristics
HC PD HD CRF
Number 33 40 23 46
Age (years) 6.0a 10.1 12.7 10.3
(0.8–17.5) (1.7–18.3) (1.7–19.2) (0.5–19.9)
Duration of
dialysis (years)
1.4 2.2
(0.2–8.9) (0.4–7.2)
GFR 15
(ml/min/1.73m2) (4–50)
Results are presented as median (range).
aThe median age of HC is lower than that of PD, HD and CRF
children (P<0.05).
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using a dot plot of forward scatter (FSC) vs side scatter. To
adjust the monocyte population, PE-conjugated anti-CD14
mAb was used; for the neutrophils anti-CD16 was used.
Peripheral blood mononuclear cells from a buffy coat of a
healthy person were included in every FACS analysis to
control for interassay variations. A total of 20 000 counts
was taken for each leukocyte sample. The positively labelled
fraction was determined by comparing with an isotype-
matched control antibody. The percentages of FcgR- and
CR-positive cells were calculated. Fluorescence-labelled
mAb are used to detect certain cell receptors. The number
of receptors per cell is directly related to the intensity of the
fluorescence, measured by the FACS after incubation of the
cells with these antibodies. The mean fluorescence intensity
(MFI) is the average fluorescence intensity of all analysed
cells. Data are given as percentages of receptor-positive cells
and MFI.
The study was approved by the Medical Ethical Review
Committee of the hospital and written informed consent was
obtained from children or their parents or both.
Statistical analysis
The results are expressed as medians and ranges. Differences
between all groups were tested with the Kruskal–Wallis
one-way analysis of variance (non-parametric ANOVA).
Differences between two groups were tested with the non-
parametric unpaired Mann–Whitney test.
Results
CD16 (FcgRIII)
Percentage of receptor-positive cells. The percentages
of CD16þ lymphocytes, which represent the natural
killer cell population, were lower in PD, HD and CRF
compared with HC children (Figure 1). All neutrophils
were positive for CD16, whereas only 20% of the
monocytes were positive for CD16. The percentages of
CD16þ monocytes were slightly lower in CRF (18%)
compared with HC (22%; P<0.01). No differences
were found between PD, HD and CRF children.
MFI. The CD16MFI was not different among the
groups (Table 3).
CD32 (FcgRII)
Percentage of receptor-positive cells. The percentages
of CD32þ lymphocytes were lower in PD, HD and
CRF children compared with HC (P<0.01; Figure 2).
Monocytes and neutrophils were all positive for CD32.
MFI. The CD32MFI of lymphocytes, monocytes and
neutrophils was lower in PD, HD and CRF children
compared with HC (Table 3).
CD64 (FcgRI)
Percentage of receptor-positive cells. Lymphocytes
were not positive for CD64 whereas both monocytes
and neutrophils were positive for CD64.
Table 3. The median (range) of FcgR and CR expressions (MFI)
on WBC
HC PD HD CRF
CD16 Ly 41 (17–106) 36 (14–72) 37 (13–56) 35 (13–130)
Mo 53 (21–109) 45 (19–93)a 58 (8–88) 48 (13–151)
Neu 167 (57–282) 138 (46–345) 145 (59–268) 151 (43–418)
CD32 Ly 156 (21–905) 33 (11–245)b 33 (15–280)c 35 (17–356)b
Mo 77 (37–308) 54 (36–141)b 55 (37–160)b 52 (16–251)b
Neu 69 (39–162) 47 (30–112)b 51 (40–83)c 50 (29–108)b
CD64 Mo 50 (14–92) 51 (27–105) 45 (23–72) 43 (18–91)
Neu 13 (6–66) 14 (9–58) 13 (5–27) 13 (7–66)
CD11bLy 15 (11–38) 19 (11–42)c 26 (11–82)d 27 (11–57)b
Mo 28 (17–61) 36 (16–79)e 39 (16–76)d 39 (15–100)b
Neu 25 (15–62) 43 (12–217)b 42 (18–129)d 44 (15–411)b
CD35 Ly 47 (18–137) 30 (6–62)b 30 (19–131)d 31 (14–82)b
Mo 17 (9–180) 14 (9–113) 19 (9–74) 12 (8–105)
Neu 22 (11–73) 17 (8–56) 32 (9–67)f 15 (8–64)c
Ly, lymphocytes; Mo, monocytes; Neu, neutrophils. The CD16þ
lymphocyte population represents the natural killer cells.
aPD vs HD: P¼ 0.03.
bP<0.001; cP<0.01; dP<0.05; eP¼ 0.057 when compared with HC.
fHD vs CRF: P¼ 0.04.
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Fig. 2. Proportions of FcgRII (CD32)-positive lymphocytes. Box-
and-whisker plot; minimum, maximum, 25% and 75% percentiles
and median. ***P<0.001.
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Fig. 1. Proportions of FcgRIII (CD16)-positive lymphocytes
(natural killer cells). Box-and-whisker plot; minimum, maximum,
25% and 75% percentiles and median. **P<0.01, ***P<0.001.
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MFI. The expression of CD64 on neutrophils and
monocytes was low and not different between the
groups (Table 3).
CD11b (CR3)
Percentage of receptor-positive cells. The fraction of
CD11bþ lymphocytes was 20% in PD children
(P<0.01), 28% in HD [not significant (NS)] and 24%
in CRF patients (NS) compared with 27% in HC. PD
children had a lower percentage of CD11bþ lympho-
cytes than HD and CRF children (P<0.01). Both
monocytes and neutrophils were positive for CD11b.
MFI. The MFI of CD11b on lymphocytes were higher
in PD, HD and CRF compared with HC (Table 3).
The CD11b expression on monocytes was higher in
HD and CRF than in HC (Table 3). For the PD group,
this was just below significance (P ¼ 0.057). The MFI
of CD11b on neutrophils was also higher in PD, HD
and CRF children compared with HC (Table 3).
CD35 (CR1)
Percentage of receptor-positive cells. The percentages
of CD35þ lymphocytes were lower in HD and CRF
compared with HC children. In PD children, the
difference was not significant (Figure 3). Both mono-
cytes and neutrophils were positive for CD35.
MFI. The MFI of CD35 on lymphocytes were lower
in PD, HD and CRF children compared with HC
(Table 3). No differences were found in the MFI of
CD35 on monocytes between the groups. The MFI of
CD35 on neutrophils was lower only in CRF children
compared with HC (Table 3). Furthermore, CRF
children had a slightly lower CD35 expression on
neutrophils compared with HD (Table 3).
Discussion
The possible differences of FcgR and CR expression
on WBC between children with chronic renal failure,
whether dialysed or not, and their healthy controls
were investigated in this study. Differences were found
especially for FcgRII (CD32) and CR3 (CD11b) on all
cell populations and for CR1 (CD35) only on lympho-
cytes. The percentages of CD32þ lymphocytes, mono-
cytes and neutrophils and CD32 MFI were lower in
PD, HD and CRF children in comparison with HC.
On the other hand, CD11bMFI, but not the percentage
of positive cells, was higher on lymphocytes, monocytes
and neutrophils in all patient groups compared with
HC. Compared with HC, CD35 expression on lympho-
cytes was reduced in children with chronic renal failure.
Differences between the FcgRs or CRs were not studied
by age group; therefore, we cannot exclude completely
that the differences we found are related to age, since
the groups were not equally matched for age. However,
this possibility is doubtful, since there was no direct
correlation between receptor expression and age, except
for the percentage of CD32þ cells (data not shown;
r¼0.4, P<0.001). Moreover, statistically significant
differences were found in all patient groups in
comparison with controls. Therefore, we think that
the most probable explanation for the differences that
we found is the uraemic state of the patients.
It is difficult to compare our results with other studies
performed in dialysis patients, because many studies
observed the effect of the dialysis procedure itself on
membrane expression and, therefore, did not include
normal controls. Furthermore, the methods and the
expressions of results are often different, which makes
comparison impossible.
It is well established that the binding of opsonized
particles to FcgR and CR enhances the efficiency of
phagocytosis [12]. The exact mechanism behind the
increased susceptibility to infections in dialysis patients
has still not been elucidated. The lower FcgRII expres-
sion on monocytes and neutrophils might result in a
reduced phagocytic capacity and, thus, increased sus-
ceptibility to infections. This assumption is strength-
ened by a study by Rossmann et al. [13] who found
a positive correlation between macrophage FcgRII
expression and FcgR function.
CR3 is not competent to mediate phagocytosis in
resting unactivated phagocytes, but this receptor is
activated after the phagocyte is exposed to cytokines
and chemoattractants [14]. The increased CR3 expres-
sion in our patients might be a reflection of a state of
chronic inflammation caused by chronic renal failure.
The consequence of the combination of a lower FcgRII
and a higher CR3 expression in children with renal
failure remains unclear.
The influence of lymphocyte FcgR and CR expres-
sion on the regulation of antibody production in
humans is not understood completely. In one study
performed on mice, Takai et al. [15] found a negative
feedback mechanism between FcgRII expression and
antibody production. If this was the case in the
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Fig. 3. Proportions of CR1 (CD35)-positive lymphocytes. Box-and-
whisker plot; minimum, maximum, 25% and 75% percentiles and
median. P<0.05, ***P<0.001.
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population of our present study, high IgG levels would
have been expected. However, we previously reported
the presence of low Ig levels in the same population of
children with chronic renal failure [16]. Reduced
FcgRII expression and low Ig serum levels together
might, therefore, result in a reduced capacity to kill
micro-organisms. The exact role of CD35 (CR1) on
B lymphocytes in the humoral immune response
remains unclear. Both activating and inhibiting effects
have been observed [17].
It has been demonstrated that, in children with
solid tumours, treatment with granulocyte/macro-
phage colony-stimulating factor (GM-CSF) results
in a decline of FcgRII and FcgRIII expression on
neutrophils combined with an increase of CR3 [18].
However, an increase of the expression of FcgRII
was found on monocytes. Only one study in adult
peritoneal dialysis patients reported increased plasma
GM-CSF levels [19]. Thus, it might be that the reduced
FcgRII expression combined with the increased CR3
expression found in our study could be caused by
increased GM-CSF plasma levels. This hypothesis
should be investigated further, because no information
is actually available on plasma GM-CSF levels in
children with chronic renal failure.
The expression of FcgR and CR on WBC is
regulated by cytokines [1,11,20]. Interferon-g (IFN-g)
is an important cytokine for the killing of bacteria
by macrophages. After IFN-g treatment, an increase
of FcgRI expression is observed on monocytes from
newborns and adults. However, FcgRII expression
on monocytes increased only in newborns, but not
in adults [21]. Erbe et al. [20] demonstrated an
upregulation only of FcgRI on monocytes and neutro-
phils in vitro after IFN-g treatment [20]. Pan et al. [22]
found an increased expression of FcgRII and FcgRIII
on human endothelial cells after stimulation with
IFN-g. Gasparoni et al. [23] showed that in infants
the synthesis of IFN-g by CD4þ and CD8þ cells
is impaired when compared with older children and
adults. Thus, the differences in cytokine produc-
tion by lymphocytes and monocytes, which is related
to age and state of uraemia, might theoretically play
a role in the alterations of FcgR and CR expression
on WBC. However, this was not investigated in our
study.
The expressions of the other Fcg receptors were
not different among the groups, except for a slightly
lower FcgRIII (CD16)-positive monocyte population
in CRF children when compared with HC. This is in
contrast to other studies, performed in adult peritoneal
dialysis and haemodialysis patients, which described
a higher CD16þ monocyte population [7–9]. CD16
appears on the cell surface of monocytes during their
maturational process. This might imply that mono-
cytes from children with chronic renal failure are
less mature compared with their healthy age-matched
controls and, possibly, also when compared with adult
patients with chronic renal failure. For CR1 (CD35)
only, the lymphocytes of the patient groups showed
lower percentages of CD35þ cells combined with lower
MFI than HC – something that might also influence
antibody production by B cells.
In summary, children with chronic renal failure,
whether dialysed or not, showed a down-regulation
of FcgRII (CD32) on lymphocytes, monocytes and
neutrophils, combined with an upregulation of CR3
(CD11b) expression levels. Furthermore, CR1 (CD35)
expression is reduced on lymphocytes in children with
chronic renal failure. Whether or not these altera-
tions might result in the diminished effectiveness of the
immune system is speculative.
Acknowledgements. This study was supported by the Dutch
Kidney Foundation (grant C95.1464) and by Baxter.
Conflict of interest statement. None declared.
References
1. Heijnen IA, van de Winkel JG. Human IgG Fc receptors.
Int Rev Immunol 1997; 16: 29–55
2. Vidarsson G, van de Winkel JGL. Fc receptor and comple-
ment receptor-mediated phagocytosis in host defence. Curr
Opin Infect Dis 1998; 11: 271–278
3. Fallman M, Andersson R, Andersson T. Signaling properties
of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phago-
cytosis of complement-opsonized particles. J Immunol 1993;
151: 330–338
4. Carcamo C, Ferna´ndez-Castro M, Selgas R, Jime´nez C, Molina
S, Vara F. Long-term continuous ambulatory peritoneal
dialysis reduces the expression of CD11b, CD14, CD16, and
CD64 on peritoneal macrophages. Perit Dial Int 1996; 16:
582–589
5. Hart PH, Jones CA, Finley-Jones JJ. Peritoneal macrophages
during peritonitis. Phenotypic studies. Clin Exp Immunol 1992;
88: 484–491
6. Nockher WA, Scherberich JE. Expanded CD14þ CD16þ
monocyte subpopulation in patients with acute and chronic
infections undergoing hemodialysis. Infect Immun 1998; 66:
2782–2790
7. Brauner A, Lu Y, Hallden G, Hylander B, Lundahl J. Difference
in the blood monocyte phenotype between uremic patients
and healthy controls: its relation to monocyte differentiation
into macrophages in the peritoneal cavity. Inflammation 1998;
22: 55–66
8. Kawanaka N, Nagake Y, Yamamura M, Makino H. Expression
of Fc gamma receptor III (CD16) on monocytes during hemo-
dialysis in patients with chronic renal failure. Nephron 2002;
90: 64–71
9. Sester U, Sester M, Heine G, Kaul H, Girndt M, Ko¨hler H.
Strong depletion of CD14þ CD16þ monocytes during haemo-
dialysis treatment. Nephrol Dial Transplant 2001; 16: 1402–1408
10. Wasik M, Blaim M, Kolewska D, Janota-Krawczyk E,
Tomaszewska P, Sieniawska M. Changes in the phagocytic
cells in children treated with continuous ambulatory peritoneal
dialysis. Archiv Immunol Ther Exp 1997; 45: 189–194
11. Schwartz GJ, Haycock GB, Edelmann CMJ, Spitzer A.
A simple estimate of glomerular filtration rate in children
derived from body length and plasma creatinine. Pediatrics
1976; 58: 259–263
12. Wallace PK, Howell AL, Fanger MW. Role of Fc gamma
receptors in cancer and infectious disease. J Leukoc Biol 1994;
55: 816–826
13. Rossman MD, Ruiz P, Comber P, Gomez F, Rottem M,
Schreiber AD. Modulation of macrophage Fc gamma receptors
by rGM-CSF. Exp Hematol 1993; 21: 177–183
2300 A. H. M. Bouts et al.
 at Institute of Social Studies on A
ugust 10, 2015
http://ndt.oxfordjournals.org/
D
ow
nloaded from
 
14. Jones SL, Lindberg P, Brown EJ. Phagocytosis. In: Paul WE,
ed. Fundamental Immunology. Lippincott-Raven, Philadelphia:
1999; 1003–1005
15. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV.
Augmented humoral and anaphylactic responses in Fc gamma
RII-deficient mice. Nature 1996; 379: 346–349
16. Bouts AHM, Davin JC, Krediet RT et al. Immunoglobulins in
chronic renal failure of childhood: effects of dialysis modalities.
Kidney Int 2000; 58: 629–637
17. Chen Z, Koralov SB, Kelsoe G. Regulation of humoral
immune response by CD21/CD35. Immunol Rev 2000; 176:
194–204
18. van Pelt LJ. Phenotypical Analysis of Neutrophils and Mono-
cytes during In Vivo Therapy with Granulocyte–Macro-
phage Colony Stimulating Factor in Children with Solid
Tumors. Thesis, University of Amsterdam, The Netherlands
19. Saionji K, Hamada T, Higurashi H et al. Plasma macrophage
colony-stimulating factor, granulocyte macrophage colony-
stimulating factor and granulocyte colony-stimulating factor
levels in continuous ambulatory peritoneal dialysis patients. Jap
J Clin Pathol 1997; 45: 493–497
20. Erbe DV, Collins JE, Shen L, Graziano RF, Fanger MW. The
effect of cytokines on the expression and function of Fc
receptors for IgG on human myeloid cells. Mol Immunol 1990;
27: 57–67
21. Fairchild KD, Hudson RG, Douglas SD, McKenzie SE, Polin
RA. Effect of gamma interferon on expression of Fc gamma
receptors in monocytes of newborn infants and adults. Clin
Diagn Lab Immunol 1996; 3: 464–469
22. Pan LF, Kreisle A, Shi YD. Detection of Fcg receptors on
human endothelial cells stimulated with cytokines tumour
necrosis factor-alpha (TNF-a) and interferon-gamma (IFN-g).
Clin Exp Immunol 1998; 112: 533–538
23. Gasparoni A, Ciardelli L, Avanzi A, Castellazzi AM, Carini R,
Chirico G. Age-related changes in intracellular Th1/Th2 cytokine
production, immunoproliferative T lymphocyte response and
natural killer cell activity in newborns, children and adults. Biol
Neonate 2003; 84: 297–303
Received for publication: 1.8.03
Accepted in revised form: 12.5.04
IgG and complement receptors in CRF children 2301
 at Institute of Social Studies on A
ugust 10, 2015
http://ndt.oxfordjournals.org/
D
ow
nloaded from
 
